{"id":"https://openalex.org/W4249366343","doi":"https://doi.org/10.1158/1538-7445.sabcs18-lb-259","title":"Abstract LB-259: FGFR- and EGFR-driven SHP2 activation displays differential sensitivity to allosteric SHP2 inhibition","display_name":"Abstract LB-259: FGFR- and EGFR-driven SHP2 activation displays differential sensitivity to allosteric SHP2 inhibition","alternate_titles":[],"publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W4249366343","doi":"https://doi.org/10.1158/1538-7445.sabcs18-lb-259"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs18-lb-259","doi":"https://doi.org/10.1158/1538-7445.sabcs18-lb-259","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-lb-259","pdf_url":null,"source":{"id":"https://openalex.org/S4306510252","display_name":"Experimental and Molecular Therapeutics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Molecular Therapeutics","raw_type":"proceedings-article"},"parent_works":[],"lineage":["https://openalex.org/W4249366343"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049400334","display_name":"Huai-Xiang Hao","orcid":"https://orcid.org/0000-0001-8291-6511","observed_orcids":["https://orcid.org/0000-0001-8291-6511"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huaixiang Hao","raw_affiliation_strings":["Novartis Insts. for BioMedical Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Insts. for BioMedical Research, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112085916","display_name":"Hengyu Lu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hengyu Lu","raw_affiliation_strings":["Novartis Insts. for BioMedical Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Insts. for BioMedical Research, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100322160","display_name":"Chen Liu","orcid":"https://orcid.org/0000-0002-4236-5476","observed_orcids":["https://orcid.org/0000-0002-4236-5476"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chen Liu","raw_affiliation_strings":["Novartis Insts. for BioMedical Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Insts. for BioMedical Research, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041672891","display_name":"Matthew J. LaMarche","orcid":"https://orcid.org/0000-0002-6588-2302","observed_orcids":["https://orcid.org/0000-0002-6588-2302"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew LaMarche","raw_affiliation_strings":["Novartis Insts. for BioMedical Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Insts. for BioMedical Research, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040093136","display_name":"Jeffrey A. Engelman","orcid":"https://orcid.org/0009-0004-0775-4523","observed_orcids":["https://orcid.org/0009-0004-0775-4523"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey A. Engelman","raw_affiliation_strings":["Novartis Insts. for BioMedical Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Insts. for BioMedical Research, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004171995","display_name":"Peter S. Hammerman","orcid":"https://orcid.org/0009-0006-9143-899X","observed_orcids":["https://orcid.org/0009-0006-9143-899X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter S. Hammerman","raw_affiliation_strings":["Novartis Insts. for BioMedical Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Insts. for BioMedical Research, Cambridge, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025118565","display_name":"Giordano Caponigro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giordano Caponigro","raw_affiliation_strings":["Novartis Insts. for BioMedical Research, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Insts. for BioMedical Research, Cambridge, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"LB","last_page":"259"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/shp2","display_name":"SHP2","score":0.9769999980926514},{"id":"https://openalex.org/keywords/shp099","display_name":"SHP099","score":0.9959999918937683},{"id":"https://openalex.org/keywords/fibroblast-growth-factor-receptor","display_name":"fibroblast growth factor receptor","score":0.9810000061988831},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":1.0},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinases","display_name":"receptor tyrosine kinase","score":0.8840000033378601},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.7720000147819519},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.7400000095367432},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7490000128746033},{"id":"https://openalex.org/keywords/ras-activation","display_name":"Ras activation","score":0.6349999904632568},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.7049999833106995},{"id":"https://openalex.org/keywords/cancer-cell-lines","display_name":"cancer cell lines","score":0.8149999976158142},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6179999709129333}],"concepts":[{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.7890688180923462},{"id":"https://openalex.org/C82867764","wikidata":"https://www.wikidata.org/wiki/Q24780051","display_name":"Fibroblast growth factor receptor","level":4,"score":0.7544372081756592},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.7448742389678955},{"id":"https://openalex.org/C128240485","wikidata":"https://www.wikidata.org/wiki/Q786998","display_name":"Autocrine signalling","level":3,"score":0.7019525766372681},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.6093911528587341},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5089423656463623},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.49076899886131287},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4618579149246216},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.46001243591308594},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.4518243670463562},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4368228614330292},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41922321915626526},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4003298580646515},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3799084722995758},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.35928863286972046},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35394859313964844},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.34411922097206116},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15844261646270752},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07620537281036377}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs18-lb-259","doi":"https://doi.org/10.1158/1538-7445.sabcs18-lb-259","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-lb-259","pdf_url":null,"source":{"id":"https://openalex.org/S4306510252","display_name":"Experimental and Molecular Therapeutics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Molecular Therapeutics","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3000801543","https://openalex.org/W2741796373","https://openalex.org/W3085529787","https://openalex.org/W2741785524","https://openalex.org/W2468923062","https://openalex.org/W4245061930","https://openalex.org/W4245057006","https://openalex.org/W2944344791","https://openalex.org/W4282981156","https://openalex.org/W7148973025"],"abstract_inverted_index":{"Introduction:":[0],"The":[1,292],"non-receptor":[2],"protein":[3],"tyrosine":[4,14],"phosphatase":[5],"SHP2":[6,28,39,71,74,173,254,261,303,309,315,349,356],"mediates":[7],"RAS":[8],"activation":[9,98,142,214,289,350],"downstream":[10],"of":[11,57,66,89,134,207,290,302,361],"various":[12,95,116],"receptor":[13],"kinases":[15],"(RTKs).":[16],"Cancer":[17,366,380],"cell":[18,91,126,152,163,168,238,249,266],"lines":[19,92,153,169,239,250],"dependent":[20,252],"on":[21,136,253],"RTK":[22],"signaling":[23],"are":[24,154,233,251,256],"generally":[25],"sensitive":[26,171],"to":[27,37,53,61,69,108,145,158,161,172,224,227,259,264,271,307,354],"genetic":[29],"knockdown":[30,174],"but":[31,255],"differ":[32],"widely":[33],"in":[34,122,143,179,236],"their":[35,106],"sensitivity":[36,68,107,353],"allosteric":[38,70,260,308,355],"inhibitors":[40,55,72,199,322],"such":[41,318],"as":[42,319],"SHP099.":[43,208],"A":[44],"recent":[45],"report":[46],"suggested":[47],"that":[48,246],"FGFR":[49,81,97,198,295],"can":[50,201],"drive":[51],"resistance":[52,306],"MAPK":[54,112,211,321],"independently":[56],"SHP2.":[58],"We":[59,85,128,149],"sought":[60],"understand":[62],"the":[63,131,287,299,362],"molecular":[64],"basis":[65],"differential":[67,352],"when":[73],"is":[75,284],"activated":[76,294],"by":[77,94,281,286],"different":[78],"RTKs,":[79],"particularly":[80],"versus":[82],"EGFR.Experimental":[83],"procedures:":[84],"profiled":[86],"a":[87,273],"panel":[88],"cancer":[90],"driven":[93],"wild-type":[96],"(receptor":[99],"amplification":[100],"or":[101],"autocrine":[102],"ligand":[103],"mediated)":[104],"for":[105,240,326,365],"SHP099":[109,120,135,159,176,191,225],"and":[110,119,138,175,200,304,347],"characterized":[111],"pathway":[113,140,212,279],"inhibition":[114,280,357],"at":[115,182],"time":[117,184],"points":[118],"doses,":[121],"comparison":[123],"with":[124,197,204,217,320],"EGFR-driven":[125,162,228,265,348],"lines.":[127,164,267],"also":[129,221],"compared":[130,160,226,263],"inhibitory":[132],"effects":[133],"FGFR-":[137,346],"EGFR-mediated":[139],"feedback":[141,213,229,288,293],"response":[144],"MEK":[146,218],"inhibitor":[147,219,316],"treatment.Results:":[148],"find":[150],"FGFR-driven":[151,167,210,248,268,313],"often":[155],"more":[156,222],"resistant":[157,223,258],"Those":[165],"SHP099-resistant":[166],"were":[170],"inhibited":[177],"p-ERK":[178,187,275],"those":[180],"cells":[181,269],"earlier":[183],"points.":[185],"However,":[186],"quickly":[188],"rebounded":[189],"after":[190],"treatment,":[192],"which":[193,283],"was":[194,220],"not":[195],"observed":[196],"be":[202,324],"attenuated":[203],"high":[205],"concentrations":[206],"Consistently,":[209],"following":[215,277],"treatment":[216],"activation.":[230],"Additional":[231],"studies":[232],"being":[234],"performed":[235],"isogenic":[237],"direct":[241],"comparison.Conclusions:":[242],"Our":[243],"findings":[244],"suggest":[245],"many":[247],"intrinsically":[257],"inhibition,":[262],"tend":[270],"have":[272],"quick":[274],"rebound":[276],"initial":[278],"SHP099,":[282],"mediated":[285],"FGFR.":[291],"likely":[296],"efficiently":[297],"promotes":[298],"open":[300],"conformation":[301],"causes":[305],"inhibitors.":[310],"For":[311],"certain":[312],"cancers,":[314],"combinations":[317],"might":[323],"needed":[325],"sustained":[327],"efficacy.Citation":[328],"Format:":[329],"Huaixiang":[330],"Hao,":[331],"Hengyu":[332],"Lu,":[333],"Chen":[334],"Liu,":[335],"Matthew":[336],"LaMarche,":[337],"Jeffrey":[338],"A.":[339],"Engelman,":[340],"Peter":[341],"S.":[342],"Hammerman,":[343],"Giordano":[344],"Caponigro.":[345],"displays":[351],"[abstract].":[358],"In:":[359],"Proceedings":[360],"American":[363],"Association":[364],"Research":[367],"Annual":[368],"Meeting":[369],"2019;":[370],"2019":[371],"Mar":[372],"29-Apr":[373],"3;":[374],"Atlanta,":[375],"GA.":[376],"Philadelphia":[377],"(PA):":[378],"AACR;":[379],"Res":[381],"2019;79(13":[382],"Suppl):Abstract":[383],"nr":[384],"LB-259.":[385]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4249366343","counts_by_year":[],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2022-05-12T00:00:00"}
